GB9304919D0
(en)
*
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
US5869511A
(en)
*
|
1994-03-09 |
1999-02-09 |
Pfizer Inc. |
Isoxazoline compounds as inhibitors of TNF release
|
US5786354A
(en)
*
|
1994-06-21 |
1998-07-28 |
Celltech Therapeutics, Limited |
Tri-substituted phenyl derivatives and processes for their preparation
|
US6245774B1
(en)
*
|
1994-06-21 |
2001-06-12 |
Celltech Therapeutics Limited |
Tri-substituted phenyl or pyridine derivatives
|
GB9412571D0
(en)
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
GB9412573D0
(en)
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US7491740B2
(en)
*
|
2001-06-08 |
2009-02-17 |
Cytokine Pharmasciences, Inc. |
Isoxazoline compounds having MIF antagonist activity
|
EP0934307B1
(en)
|
1996-06-19 |
2011-04-27 |
Aventis Pharma Limited |
Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
|
GB9622363D0
(en)
|
1996-10-28 |
1997-01-08 |
Celltech Therapeutics Ltd |
Chemical compounds
|
EP0946523A1
(en)
|
1996-12-23 |
1999-10-06 |
Celltech Therapeutics Limited |
Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
|
GB9705361D0
(en)
|
1997-03-14 |
1997-04-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US6022977A
(en)
*
|
1997-03-26 |
2000-02-08 |
Dupont Pharmaceuticals Company |
Dynamic resolution of isoxazoline thioesters to isoxazoline carboxylic acids
|
GB9713087D0
(en)
*
|
1997-06-20 |
1997-08-27 |
Celltech Therapeutics Ltd |
Chemical compounds
|
DZ3019A1
(fr)
*
|
1999-03-01 |
2005-05-20 |
Smithkline Beecham Corp |
Utilisation d'un inhibiteur de pde4 dans la préparation d'un médicament contre la copd.
|
GB9914258D0
(en)
*
|
1999-06-18 |
1999-08-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
ATE320800T1
(de)
|
1999-08-21 |
2006-04-15 |
Altana Pharma Ag |
Synergistische kombination von roflumilast und salmeterol
|
CN1137888C
(zh)
*
|
1999-09-17 |
2004-02-11 |
株式会社Lgci |
半胱氨酰天冬氨酸蛋白酶抑制剂
|
KR100399361B1
(ko)
|
1999-11-04 |
2003-09-26 |
주식회사 엘지생명과학 |
캐스파제 억제제 함유 치료제 조성물
|
GB9924862D0
(en)
*
|
1999-10-20 |
1999-12-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
DE19953024A1
(de)
*
|
1999-11-04 |
2001-05-10 |
Merck Patent Gmbh |
Isoxazolderivate als Phosphodiesterase VII-Hemmer
|
GB2362101A
(en)
*
|
2000-05-12 |
2001-11-14 |
Astrazeneca Ab |
Treatment of chronic obstructive pulmonary disease
|
EP1389468A4
(en)
*
|
2001-05-23 |
2007-01-10 |
Tanabe Seiyaku Co |
COMPOSITIONS PROMOTING THE GUISON OF A BONE FRACTURE
|
KR20040007583A
(ko)
*
|
2001-05-23 |
2004-01-24 |
다나베 세이야꾸 가부시키가이샤 |
연골 질환의 재생치료용 조성물
|
AU2002312933B2
(en)
*
|
2001-05-29 |
2007-12-06 |
Schering Ag |
CDK inhibiting pyrimidines, production thereof and their use as medicaments
|
AU2002322720B2
(en)
|
2001-07-25 |
2008-11-13 |
Raptor Pharmaceutical Inc. |
Compositions and methods for modulating blood-brain barrier transport
|
AR039385A1
(es)
*
|
2002-04-19 |
2005-02-16 |
Astrazeneca Ab |
Derivados de tioxantina como inhibidores de la mieloperoxidasa
|
AU2003301903A1
(en)
*
|
2002-11-06 |
2004-06-03 |
Bristol-Myers Squibb Company |
Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
BRPI0409229A
(pt)
|
2003-04-01 |
2006-03-28 |
Applied Research Systems |
inibidores das fosfodiesterases na infertilidade
|
KR100594544B1
(ko)
*
|
2003-08-27 |
2006-06-30 |
주식회사 엘지생명과학 |
이소옥사졸린 구조를 갖는 캐스파제 저해제
|
AU2004268847A1
(en)
*
|
2003-08-29 |
2005-03-10 |
Ranbaxy Laboratories Limited |
Inhibitors of phosphodiesterase type-IV
|
SE0302756D0
(sv)
*
|
2003-10-17 |
2003-10-17 |
Astrazeneca Ab |
Novel Compounds
|
WO2005051931A2
(en)
*
|
2003-11-26 |
2005-06-09 |
Ranbaxy Laboratories Limited |
Phosphodiesterase inhibitors
|
CN102532048B
(zh)
|
2004-03-05 |
2015-06-24 |
日产化学工业株式会社 |
异噁唑啉取代苯甲酰胺化合物的制备中间体
|
EP1727542A4
(en)
*
|
2004-03-26 |
2009-08-05 |
Cytokine Pharmasciences Inc |
COMPOUNDS, COMPOSITIONS, METHODS OF MANUFACTURE, AND METHODS OF USE FOR INHIBITING MACROPHAGE MIGRATION INHIBITION FACTOR
|
US20080009535A1
(en)
*
|
2004-08-30 |
2008-01-10 |
Sarala Balachandran |
Inhibitors of phosphodiesterase type-IV
|
SE0402591D0
(sv)
*
|
2004-10-25 |
2004-10-25 |
Astrazeneca Ab |
Novel use
|
MY140748A
(en)
*
|
2004-12-06 |
2010-01-15 |
Astrazeneca Ab |
Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
|
ES2370788T3
(es)
*
|
2005-02-07 |
2011-12-22 |
Aerocrine Ab |
Controlar flujo de aliento exhalado durante análisis.
|
WO2006097273A1
(en)
*
|
2005-03-15 |
2006-09-21 |
Ganial Immunotherapeutics Inc. |
Compounds having immunomodulator activity
|
PL1889198T3
(pl)
|
2005-04-28 |
2015-04-30 |
Proteus Digital Health Inc |
System farmakologiczno-informatyczny
|
EP1879884B1
(en)
*
|
2005-05-03 |
2010-08-25 |
Ranbaxy Laboratories Limited |
Azole-based phosphodiesterase inhibitors
|
EP1928437A2
(en)
|
2005-08-26 |
2008-06-11 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
EP2258359A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation with sabcomelin
|
EP1940389A2
(en)
|
2005-10-21 |
2008-07-09 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
EP2314289A1
(en)
|
2005-10-31 |
2011-04-27 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
US20100216734A1
(en)
*
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
CA2643199A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
EP2377531A2
(en)
|
2006-05-09 |
2011-10-19 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
US20100009983A1
(en)
*
|
2006-05-09 |
2010-01-14 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
EP2026813A2
(en)
|
2006-05-09 |
2009-02-25 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
TW200804383A
(en)
*
|
2006-06-05 |
2008-01-16 |
Astrazeneca Ab |
New compounds
|
WO2008030651A1
(en)
*
|
2006-09-08 |
2008-03-13 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
WO2008036682A2
(en)
|
2006-09-18 |
2008-03-27 |
Raptor Pharmaceutical Inc. |
Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
AU2007299920A1
(en)
*
|
2006-09-19 |
2008-03-27 |
Braincells, Inc. |
PPAR Mediated Modulation of Neurogenesis
|
US20100029728A1
(en)
*
|
2006-09-22 |
2010-02-04 |
Ranbaxy Laboratories Limited |
Phosphodiesterase inhibitors
|
WO2008151257A2
(en)
|
2007-06-04 |
2008-12-11 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
WO2009149279A2
(en)
|
2008-06-04 |
2009-12-10 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
WO2010009319A2
(en)
|
2008-07-16 |
2010-01-21 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
ES2919563T3
(es)
|
2009-02-20 |
2022-07-27 |
Enhanx Biopharm Inc |
Sistema de administración de medicamentos a base de glutatión
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
JP2012526144A
(ja)
|
2009-05-06 |
2012-10-25 |
ラボラトリー スキン ケア インコーポレイテッド |
活性物質−リン酸カルシウム粒子複合体を含む経皮送達組成物およびその使用方法
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
US20120077778A1
(en)
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
EP3366698A1
(en)
|
2011-03-01 |
2018-08-29 |
Synergy Pharmaceuticals Inc. |
Guanylate cyclase c agonists
|
MX350825B
(es)
|
2011-03-31 |
2017-09-22 |
Bayer Ip Gmbh |
3-fenilisoxazolin-5-carboxamidas y 3-fenilisoxazolin-5-tioamidas de accion herbicida y fungicida.
|
EP2804603A1
(en)
|
2012-01-10 |
2014-11-26 |
President and Fellows of Harvard College |
Beta-cell replication promoting compounds and methods of their use
|
US20150064221A1
(en)
|
2012-04-17 |
2015-03-05 |
Niranjan Y. Sardesai |
Compounds having immunomudulator activity
|
KR101977920B1
(ko)
*
|
2012-09-25 |
2019-05-13 |
바이엘 크롭사이언스 악티엔게젤샤프트 |
제초 작용을 가지는 3-페닐이속사졸린 유도체
|
WO2014081752A1
(en)
*
|
2012-11-20 |
2014-05-30 |
Biogen Idec Ma Inc. |
S1p and/or atx modulating agents
|
CA2902348C
(en)
|
2013-02-25 |
2021-11-30 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
JP2016514671A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼのアゴニストおよびその使用
|
EP2968439A2
(en)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
CA2913737A1
(en)
|
2013-06-05 |
2014-12-11 |
Synergy Pharmaceuticals, Inc. |
Ultra-pure agonists of guanylate cyclase c, method of making and using same
|
CN103381157A
(zh)
*
|
2013-07-04 |
2013-11-06 |
丁圣雨 |
Chukrasone B在治疗慢性阻塞性肺疾病的药物中的应用
|
CN105979959B
(zh)
|
2013-08-09 |
2021-11-30 |
阿德利克斯公司 |
用于抑制磷酸盐转运的化合物和方法
|
CN106573924B
(zh)
*
|
2014-04-22 |
2019-06-25 |
诺华股份有限公司 |
作为LpxC抑制剂的异噁唑啉异羟肟酸衍生物
|
PL3638665T3
(pl)
|
2017-06-13 |
2021-12-27 |
Bayer Aktiengesellschaft |
Chwastobójczo skuteczne 3-fenyloizoksazolino-5-karboksyamidy kwasów i estrów tetrahydro- i dihydrofuranokarboksylowych
|
HUE056695T2
(hu)
|
2017-06-13 |
2022-03-28 |
Bayer Ag |
Tetrahidro- és dihidrofurán-karbonsav-amidok gyomirtó 3-fenilizoxazolin-5-karboxamidjai
|
JP7198519B2
(ja)
|
2017-08-17 |
2023-01-04 |
バイエル・アクチエンゲゼルシヤフト |
シクロペンチルカルボン酸類及びエステル類の除草活性3-フェニル-5-トリフルオロメチルイソオキサゾリン-5-カルボキサミド類
|
PL3743411T3
(pl)
|
2018-01-25 |
2023-03-13 |
Bayer Aktiengesellschaft |
Herbicydowo czynne 3-fenyloizoksazolino-5-karboksyamidy z pochodnych kwasów cyklopentenylokarboksylowych
|
CA3133025A1
(en)
|
2019-03-12 |
2020-09-17 |
Bayer Aktiengesellschaft |
Herbicidally active 3-phenylisoxazoline-5-carboxamides of s-containing cyclopentenyl carboxylic acid esters
|
WO2020237096A1
(en)
|
2019-05-21 |
2020-11-26 |
Ardelyx, Inc. |
Combination for lowering serum phosphate in a patient
|